Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Labcorp Holdings Inc.
LH
$323.34
Name : Labcorp Holdings Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $26,222,874,624.00
EPSttm : 12.29
finviz dynamic chart for LH
Labcorp Holdings Inc.
$323.34
1.64%
$5.21
LH — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

2.59

Margin Of Safety %

-5

Put/Call OI Ratio

0.81

EPS Next Q Diff

-0.54

EPS Last/This Y

7.81

EPS This/Next Y

1.44

Price

323.4

Target Price

345.79

Analyst Recom

1.55

Performance Q

29.16

Upside

-17.8%

Beta

0.87

Ticker: LH




21 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-20LH281.530.281.562693
2026-07-21LH279.240.297.632705
2026-07-22LH281.470.310.272770
2026-07-23LH291.010.310.022835
2026-07-24LH296.830.310.082852
2026-07-27LH301.230.310.142859
2026-07-28LH314.360.310.202929
2026-07-29LH307.270.305.453053
2026-07-30LH315.580.430.803418
2026-07-31LH309.080.463.383727
2026-08-03LH307.590.501.083852
2026-08-04LH312.450.500.973877
2026-08-05LH313.990.500.083852
2026-08-06LH316.60.500.003849
2026-08-07LH318.950.500.843852
2026-08-10LH321.230.5061.393884
2026-08-11LH322.80.820.214681
2026-08-12LH323.420.810.444692
2026-08-13LH322.750.810.034690
2026-08-14LH318.240.810.794696
2026-08-17LH323.40.811.544704
DateSymbolLatestP/C OIP/C VolTotal OI
21 items Current Page1 of 1




18 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-20LH281.559.652.518.01
2026-07-21LH279.419.651.518.01
2026-07-22LH281.399.667.818.01
2026-07-23LH291.109.698.418.01
2026-07-24LH296.809.682.318.01
2026-07-27LH301.239.676.918.01
2026-07-28LH314.299.6109.618.01
2026-07-29LH307.009.633.218.01
2026-07-30LH315.749.691.918.01
2026-07-31LH309.079.620.318.01
2026-08-03LH307.549.653.718.01
2026-08-04LH307.549.653.718.01
2026-08-05LH313.9911.6129.018.36
2026-08-06LH316.6011.6132.618.36
2026-08-07LH319.0811.646.618.36
2026-08-13LH322.6511.334.018.35
2026-08-14LH318.0311.320.218.35
2026-08-17LH323.4011.356.818.35
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
18 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-20LH-7.45-1.223.47
2026-07-21LH-7.45-1.223.47
2026-07-22LH-7.45-1.223.47
2026-07-23LH-7.45-1.223.47
2026-07-24LH-7.45-1.223.47
2026-07-27LH-7.45-1.703.33
2026-07-28LH-7.45-1.703.33
2026-07-29LH-7.45-1.703.33
2026-07-30LH-7.45-1.703.33
2026-07-31LH-7.45-1.703.33
2026-08-03LH-7.45-2.283.33
2026-08-04LH-7.45-2.283.33
2026-08-05LH-7.92-2.283.33
2026-08-06LH-8.16-2.283.33
2026-08-10LH-8.12-1.723.37
2026-08-11LH-8.12-1.723.37
2026-08-12LH-9.32-1.722.59
2026-08-13LH-9.30-1.722.59
2026-08-14LH-7.92-1.722.59
2026-08-17LH-7.92-0.732.59
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

4.99

Avg. EPS Est. Current Quarter

4.65

Avg. EPS Est. Next Quarter

4.45

Insider Transactions

-7.92

Institutional Transactions

-0.73

Beta

0.87

Average Sales Estimate Current Quarter

3758

Average Sales Estimate Next Quarter

3721

Fair Value

307.28

Quality Score

71

Growth Score

62

Sentiment Score

83

Actual DrawDown %

0.7

Max Drawdown 5-Year %

-34.5

Target Price

345.79

P/E

26.74

Forward P/E

16.28

PEG

1.72

P/S

1.83

P/B

3.04

P/Free Cash Flow

22.7

EPS

12.09

Average EPS Est. Cur. Y​

18.35

EPS Next Y. (Est.)

19.78

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

6.99

Relative Volume

1.17

Return on Equity vs Sector %

-14.7

Return on Equity vs Industry %

0.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.34

EBIT Estimation

56.8
LH Healthcare
$323.40
📉
Swing / Pullback
Buy the dip on strong trends
37 /100
WEAK
Trend
18/20
Pullback
6/25
Volume
4/15
Valuation
5/20
TP/AR
1/10
Options
3/10
RSI
69.4
Range 1M
96.7%
Sup Dist
2.4%
🚀
Momentum Growth
Ride accelerating trends
N/A
40 /100
WEAK
Momentum
13/25
Growth
13/30
Estimates
4/20
Inst/Vol
6/15
Options
4/10
EPS Yr
11.5%
EPS NY
8.4%
52W%
98%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟡 HOLD +17.2% upside
Quality
7/30
Valuation
5/30
Growth
10/25
Stability
5/10
LT Trend
4/5
Upside
+17.2%
Quality
71
MoS
-5%
LH — P/E HistoricalDiagnostics & Research
Labcorp Holdings Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 71000
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics; and Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina.
LH

Latest News

Caricamento notizie per LH
stock quote shares LH – Laboratory Corporation of America Holdings Stock Price stock today
news today LH – Laboratory Corporation of America Holdings stock forecast ,stock prediction 2023 2024 2025
marketwatch LH – Laboratory Corporation of America Holdings yahoo finance google finance
stock history LH – Laboratory Corporation of America Holdings invest stock market
stock prices LH premarket after hours
ticker LH fair value insiders trading